Insider Purchases: Inside the Buy
Tag: hub-insiders
SSP Stock Analysis 2026: Scripps Insiders Double Down on a High-Stakes Media Turnaround
When insiders start buying stock aggressively, investors take notice. In early 2026, executives, directors, and members of the Scripps family all stepped in to buy SSP shares. The question now: is this a deep-value media turnaround or a value trap?
CSX Stock Analysis 2026: New CEO’s $1M Bet vs. Valuation Red Flags
A new CEO buying $1M in shares is always interesting. But with CSX trading near all-time highs while earnings soften, investors face a classic dilemma: operational confidence vs valuation discipline.
SOFI Stock Analysis 2026: CEO Insider Buys, Crypto Ambition, and the Path to $30
SoFi just delivered its first billion-dollar quarter, record member growth, and a fresh insider buy from CEO Anthony Noto. The fintech story is evolving from speculative startup to profitable platform — but valuation and skepticism remain. Here’s the FUNanc1al breakdown of the opportunity.
CoStar Group (CSGP) Stock Analysis 2026: Why the CEO Is Buying the Dip
After a sharp decline, CoStar Group (CSGP) insiders are stepping in to buy shares. With dominant commercial real estate data, rapid Homes.com growth, and strong institutional backing, investors are asking whether the market is underestimating the company’s long-term potential.
TTD Stock Analysis 2026: Jeff Green’s $148M Bet — Is The Trade Desk the Ultimate “Buy the Dip” Play?
The Trade Desk just got the loudest kind of bullish signal: the founder-CEO bought $148M of his own stock after an 80%+ drawdown. Institutions are stacked, shorts are circling, and valuation has finally cooled from “bubble” to “business.” The question now: is TTD a generational dip… or a beautiful trap?
NOW Stock Analysis 2026: Bill McDermott’s $3M “Strong Buy” Signal — Is ServiceNow the AI Control Tower?
ServiceNow (NOW) is fighting a valuation reset with AI-powered fundamentals. CEO Bill McDermott just made a rare $3M insider buy — a signal worth decoding.
FOUR Stock Analysis 2026: Is Shift4 a Payments Powerhouse or a Falling Knife?
Shift4 (FOUR) is a full-blown battleground stock. Founder buying, 35% short interest, heavy institutional ownership, and a forward P/E near 7. Rocket fuel — or engine trouble?
PODD Stock Analysis 2026: Is Insulet the Ultimate Growth Play or a Valuation Trap?
Insulet (PODD) just delivered 31% revenue growth and insiders are buying — yet the stock trades at 70x earnings. Is this premium medtech compounder a long-term winner or priced for perfection? Here’s the FUNanc1al breakdown.
AbCellera (ABCL) Stock Analysis: 7 Triggers for a Biotech Short Squeeze or Long-Term Multibagger?
Down 95%, heavily shorted, yet sitting on $700M in liquidity and insider conviction — AbCellera (ABCL) may be biotech’s ultimate asymmetric bet.
Hamilton Lane (HLNE) 2026 Deep Dive: Inside the $4M Insider Buy and Private Market Growth
$4M+ in insider buys. 18% revenue growth. Private markets expanding. Hamilton Lane may be a premium compounder trading 47% below its highs.
Quick links
Search
About/Leadership
Editorial Process
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
